Metabolomycs, Inc.

Metabolomycs, Inc. is a Southern California-based biotechnology company that has pioneered the clinical application of next-generation metabolomics for the study of human disease. We study the role of metabolism in health. A healthy metabolism is linked to a lower risk of chronic conditions that include diabetes, cardiovascular disease, dementia and cancer. Metabolomycs' platform utilizes biochemical signatures to identify inborn-like errors of metabolism that underlie many human illnesses.

Our MetaSync Analysis test uses precision targeted metabolomics to look deep into biochemical health. This test can often uncover health problems that would typically never be discovered by standard medical exams and routine testing.

This provides the opportunity for intervention to design individualized recommendations for diet, supplementation, lifestyle and behavior. 

© 2025-2026 Metabolomycs, Inc.